FEN1 is a prognostic biomarker for ER+ breast cancer and associated with tamoxifen resistance through the ERα/cyclin D1/Rb axisLu Xu(First Hospital of China Medical University)Annals of Translational MedicineFebruary 1, 202110.21037/atm-20-3068Cited by 24SaveCiteExport RISWatch citationsRelated PapersGALNT6 promotes breast cancer metastasis by increasing mucin-type O-glycosylation of α2M|Aging|2020|51Genome-Wide Identification of a Novel Eight-lncRNA Signature to Improve Prognostic Prediction in Head and Neck Squamous Cell Carcinoma|Frontiers in Oncology|2019|43